Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think about obesity, diabetes and weight loss. Headlines often describe them as ...

By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...

It’s no secret that starting a GLP-1 weight-loss medication is as much an emotional journey as it is a physical one. From ...

After gastric bypass surgery, 53‑year‑old Jennie Mixon reversed her Type 2 diabetes, shed half her body weight and reclaimed ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

There has been increased interest in over-the-counter GLP-1 patches. If you’re thinking about using, here’s what you should know.

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions. This is a stunning gut-brain breakthrough.

Interest in the use and impacts of glucagon-like peptide-1 receptor agonists in rheumatology has exploded over the past year, a trend that appeared to crescendo at ACR Convergence 2025. There, ...

As the Winter Olympic Games get underway, the World Anti-Doping Agency (WADA) is monitoring an unexpected class of drugs: GLP-1 receptor agonists. That means patterns of use of these drugs will be ...